A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
Clinical trial NCT05417321 · RECRUITING
Trial details
- NCT number
- NCT05417321
- Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-25
- Primary completion
- 2025-08-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.